Skip to content
JLM-BioCity
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM BIO INNOVATION
    • JLM COMPANIES
    • JLM LANDSCAPE
    • BIOTIPS
    • BLOG
    • BRIEFS
  • JOIN US
    • Our Partners
    • Become a Partner
  • JLM-BIOSYNERGY
  • CONTACT US
Menu Close
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM BIO INNOVATION
    • JLM COMPANIES
    • JLM LANDSCAPE
    • BIOTIPS
    • BLOG
    • BRIEFS
  • JOIN US
    • Our Partners
    • Become a Partner
  • JLM-BIOSYNERGY
  • CONTACT US

JLM-BioCity Innovations

  1. Home>
  2. Resources>
  3. JLM-BioCity Innovations

Image Navigation revolutionizes the line of minimally invasive dental implant treatments

May 9, 2022

Image Navigation revolutionizes the line of minimally invasive dental implant treatments with its new IGI 2.0, groundbreaking technology that ensures real-time surgical navigation for maximum

Read More »

Omnix Medical Starts Phase I Clinical Trial of their Novel Antimicrobial Agent

May 8, 2022

  New mechanism of action (MoA) addressing global increase of antimicrobial resistance (AMR) burden and shortage of potent anti-infectives JERUSALEM, Israel, April XX, 2022 —

Read More »
JLM-BioCITY Biotech stem cells

FDA Clearance to Gamida Cell for GDA-201 Treatment of Follicular & Diffuse Large B Cell Lymphomas

May 8, 2022

Gamida Cell Ltd. (Nasdaq: GMDA), the leader in nicotinamide (NAM) -enabled cell therapies for patients with hematologic and solid cancers, has received the green light

Read More »

Olive Diagnostics AI Urine Analysis Readable on The Apple Watch

May 7, 2022

Jerusalem-based Olive Diagnostics’s KG system is the world’s first 100 percent passive non-invasive real-time urine analysis sensor that can be hooked up to any toilet. This

Read More »

KAHR Published Preclinical Data Indicating Treatment Potential of Their Anti-CD47 Fusion Protein

May 3, 2022

KAHR, a Jerusalem clinical-stage cancer immunotherapy company, has just announced the publication of their preclinical data that supports the development of DSP107. DSP107 is a

Read More »

Salignostics Closes $8M Funding Round to Take Its Saliva-Based Pregnancy Test to Market

April 27, 2022

Salignostics, a Jerusalem medical startup, has raised $8 million in a Series A financing round in order to mass market their rapid saliva-based test kits.

Read More »

Nectin Therapeutics Obtained $5.4 Million Investment for Solid Tumors Immunotherapy Study

April 19, 2022

Nectin Therapeutics Ltd., a biotechnology company developing novel targeted immunotherapies, and Cancer Focus Fund, LP, a unique investment fund established in collaboration with The University

Read More »

NewStem Files FDA Pre-Submission & EMA IVDD for Revolutionary Cancer Diagnostic Device

April 19, 2022

NewStem Ltd filed for a pre-submission to the FDA for a De Novo Request and an in vitro cancer diagnostic device (IVDD) to the EMA

Read More »

Nanox Opens So. Korean Fab Plant to Produce Semiconductor Chips for Novel Digital Nanox.ARC 3D X-Ray System

April 12, 2022

Nanox (Nasdaq/TASE: ), an Israeli corporation that has developed the first solid-state digital X-ray source designed to be used in real-world medical imaging applications, has

Read More »
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Next »

JLM-BioCity Upcoming Events

JLM-BioCity-Event-3 Top Bio Executives on Career Opportunities in JLM

MON, MAY 23 · 5:00 PM IDT

3 Top Bio Executives on Career Opportunities in Jerusalem

For information and to RSVP, click here

JLM-BioCity-Event-Successful IP Strategies that Bio Investors Love

MON, MAY 23 · 5:30 PM IDT

Successful IP Strategies that Bio Investors Love

For information and to RSVP, click here

More JLM BioCity events coming soon…

What people are saying…

Moshe Lebowitz with Jerusalem Mayor Moshe Leon - Credit Dr George Lowell

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

- Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

Ian Solomon CTO, OmnySense Ltd

The JLM Biocity networking events on Zoom keeps getting better.  For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

- Ian Solomon CTO, OmnySense Ltd.

Dror Chevion Concenter BioPharma

JLM-BioCity's events are well organized with a professional approach. You can feel a "homey" atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

- Dror Chevion CEO, Concenter BioPharma

Immanuel Lerner CEO, Pepticom

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

- Immanuel Lerner CEO, Pepticom

JLM BioCity Member Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

- Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

JLM-BioCity member Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

- Zeev Malyutin, Protein Department Head, Merck KGaA

JLM-BioCity member Aurélie Schwarzbach

Such an interesting lecture and great people attending!

- Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

JLM-BioCity member Jonathan Miller

Interesting - I could see it helping people network - a good thing!

- Jonathan Miller, Founder, President, and Designer, U-Step, Neurological Walking Aids

JLM BioCity Member Yael Ophir

Great atmosphere, great people.

- Yael Ophir, Executive Director, HealthIL

JLM BioCity Member Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

JLM BioCity Member Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

- Hemda Idel, founder, SLEEP ASAP

JLM-BioCity Member Tal Or

one of the best meetups organizations and a very important source of information and connections for startups.

Tal Or, Co-Founder, ATLASense Biomed Ltd.

JLM-BioCity Member Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

Alexander Naslednikov, Founder and CEO, Med.me

<< Prev
Next >>

JLM-BioCity in THE MARKER

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Strategic Partners

Platinum

Gold

Silver

JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)

Contact us at

+972-(0)54-973-0029

info at jlm-biocity.org

Follow us

Linkedin Facebook-f Youtube

Home

About

What’s Happening

Resources

Become a Partner

Become a Member

JLM-BioSynergy

Contact Us

Copyright © 2020 JLM-BioCity | All rights reserved